BIOLARGO, INC. (BLGO)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, BIOLARGO, INC. reported revenue of $7.76M, down 56.3% from the prior year. The company ran a net loss, with a net margin of -195.6% and a gross margin of 43.9%. It held $8.31M in total assets against $6.79M in total liabilities.
Key ratios (FY2025)
43.9%
Gross margin
-191.3%
Operating margin
-195.6%
Net margin
-375.8%
Return on equity
-56.3%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.76M | $17.78M | $12.23M | $5.88M | $2.53M | $2.43M | $1.86M | $1.36M | $516.0K | — |
| Cost of Revenue | $4.36M | $9.93M | $6.08M | $3.03M | $1.43M | $1.20M | $945.0K | $743.0K | $323.0K | — |
| Gross Profit | $3.41M | $7.85M | $6.15M | $2.86M | $1.10M | $1.23M | $916.0K | $621.0K | $193.0K | $175.2K |
| Operating Income | -$14.86M | -$4.33M | -$4.58M | -$5.39M | -$6.78M | -$7.58M | -$6.70M | -$6.41M | -$5.90M | -$4.93M |
| Net Income | -$15.19M | -$4.35M | -$4.65M | -$5.13M | -$6.89M | -$9.70M | -$11.44M | -$10.70M | -$9.55M | -$8.07M |
| EPS (Diluted) | $-0.04 | $-0.01 | $-0.01 | $-0.02 | $-0.03 | — | — | — | — | — |
| Total Assets | $8.31M | $10.51M | $8.21M | $4.86M | $3.02M | $4.94M | $3.62M | $3.19M | $1.50M | $2.11M |
| Total Liabilities | $6.79M | $4.46M | $4.00M | $2.85M | $2.09M | $5.18M | $5.80M | $4.31M | $4.91M | $2.88M |
| Shareholders' Equity | $4.04M | $8.85M | $6.84M | $4.88M | $4.65M | $3.86M | -$2.15M | -$1.50M | -$4.10M | -$1.33M |
| Cash & Equivalents | $3.88M | $3.55M | $3.54M | $1.85M | $962.0K | $716.0K | $655.0K | $655.0K | $990.0K | $1.91M |
| Operating Cash Flow | -$8.30M | -$3.21M | -$2.37M | -$2.76M | -$3.94M | -$4.15M | -$4.42M | -$3.89M | -$4.28M | -$3.72M |
| Capital Expenditures | — | — | — | — | — | — | — | — | $28.7K | — |
| Shares Outstanding | — | — | 292.95M | 278.46M | — | — | — | — | — | 92.98M |